:: Altroz - News Magazine HTML Template ::

Language:

Verona Pharma News

Merck & Co. Makes a Bold Move: Acquiring Verona Pharma for $10 Billion to Expand Its Biopharmaceutical Portfolio

Ryan Peterson 10 Jul, 2025

Merck & Co., Inc. has confirmed its $10 billion acquisition of Verona Pharma, aiming to bolster its biopharmaceutical offerings with Verona's COPD treatment, Ohtuvayre. The deal, e...

Business

Merck's Bold $10B Move: Verona Pharma Shares Soar 18% on Takeover Buzz

James Carter 09 Jul, 2025

Verona Pharma's shares surged 18% following reports of a $10 billion takeover bid by Merck & Co., Inc., offering a 23% premium per share. This move aims to strengthen Merck's posit...

Verona Pharma News

Merck & Co. Makes a Bold Move: Acquiring Verona Pharma for $10 Billion to Expand Its Biopharmaceutical Portfolio

Merck's Bold $10B Move: Verona Pharma Shares Soar 18% on Takeover Buzz

Popular News

Political Unrest Sparks Massive Foreign Investor Exodus from South Korea's Financial Markets

LNG Industry Alarms: US Tariffs on Chinese Vessels Threaten Energy Dominance and Export Growth

Japan's Unemployment Rate Drops to 2.4% in December, Beating Expectations

Wall Street Dips as Trump's Steel Tariffs Stir Market Unease: A Closer Look

Asia-Pacific Markets Dip as South Korea's Political Crisis and US Economic Data Stir Concerns

How Wealthy Indian Families Use Overseas Students to Transfer Money Abroad: An RBI Investigation

Erste Group Secures Landmark €7 Billion Deal with Santander, Expanding European Banking Dominance

European Markets Show Mixed Signals Amid Economic Data and Tariff Concerns

Newsletter

Subscribe Newsletter!

Privacy Policy

Terms & Conditions

Contact Us